当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い

オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得

抽象的な

Transition Metal Complexes in Medicine from Bench to Bedside

Ahmed Berhanu*

This article explores the transformative journey of transition metal complexes in the field of medicine, tracing their evolution from laboratory bench experiments to practical applications at the patient’s bedside. Transition metals, with their unique electronic and structural properties, offer a versatile platform for designing therapeutic agents. The versatility of transition metal complexes is showcased in their applications as anticancer agents, antimicrobial therapies, and anti-inflammatory interventions. Platinum-based drugs, like cisplatin, have pioneered the use of transition metal complexes in oncology, while copper complexes show promise in combating infectious diseases. This article highlights the challenges, such as toxicity and stability, and discusses the ongoing research efforts to optimize the therapeutic potential of transition metal complexes. As these complexes continue to redefine the landscape of medicine, their journey holds the promise of innovative treatments and improved patient outcomes